What is the Impact Factor of Lung Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Lung Cancer is 5.30, ranking in quartile Q1 of Web of Science (SCIE).

Is Lung Cancer indexed in Web of Science or Scopus?

Yes, Lung Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.928 (Q1) and an H-index of 160.

Who publishes Lung Cancer and what is the Article Processing Charge (APC)?

Lung Cancer is published by Elsevier Ireland Ltd. The estimated Article Processing Charge (APC) is approximately $3,667 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Lung Cancer?

The official ISO-4 abbreviation of Lung Cancer is "LUNG CANCER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,552Hybrid

Lung Cancer

Abbreviation (ISO):LUNG CANCER

•

Identifier (ISSN):0169-5002(Print)/1872-8332(Online)

•

Publisher:Elsevier Ireland Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

5.3↑ +0.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Lung Cancer

WoS Q1

Annual Impact Factor Metric

Current (2026):5.3

Scopus SJR & RankScopus Q1

1.928

#1,552

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

160

160 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate2.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

271articles/year

30.75% Gold OA•91.9% Original Research

Aims & Scope

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.

Topics Covered (Recognized by AI)

MedicineInternal MedicinePathologyOncologyBiologyGeneticsSurgeryOncology & Cancer ResearchChemistryPhilosophyLinguisticsBiochemistryRadiology

Primary Research Areas

Medicine Respiratory System

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank80/333

IndexSCIE

JCRSCIE2026

RESPIRATORY SYSTEM

Rank16/107

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank68/333

IndexSCIE

JCISCIE2026

RESPIRATORY SYSTEM

Rank21/107

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	80/333	Q1
RESPIRATORY SYSTEM	JCRSCIE	16/107	Q1
ONCOLOGY	JCISCIE	68/333	Q1
RESPIRATORY SYSTEM	JCISCIE	21/107	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.3

Articles / Year592

Total Citations105

2025

IF4.4

Articles / Year851

Total Citations1,152

2024

IF4.5

Articles / Year614

Total Citations2,182

2023

IF5.3

Articles / Year600

Total Citations3,263

2022

IF6.081

Articles / Year426

Total Citations4,213

Year	Impact Factor	Articles / Year	Total Citations
2026	5.3	592	105
2025	4.4	851	1,152
2024	4.5	614	2,182
2023	5.3	600	3,263
2022	6.081	426	4,213
2021	5.705	605	6,674
2020	4.702	744	9,640
2019	4.599	737	13,014
2018	4.486	720	13,664
2017	—	610	12,870
2016	—	485	11,475
2015	—	498	12,577

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,552Scopus Q1SCImago Profile

Scopus Coverage:1985-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.928

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.93

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,667 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,439

3-Year Documents678

Citable Documents636

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

OncologyQ1

Pulmonary and Respiratory MedicineQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Lung Cancer (abbr: LUNG CANCER, ISSN: 0169-5002) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ireland Ltd in Netherlands since 1985. The periodical holds a Journal Impact Factor (JIF) of 5.30, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.928 (Q1), an H-index of 160.

The journal enforces rigorous peer evaluation with an average review speed of 5.9周, a publication frequency of Monthly, an annual output of approximately 271 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,667 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.